Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Antidepressant agents for the treatment of chronic pain and depression
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Antidepressant agents for the treatment of chronic pain and depression'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Pain
100%
Antidepressants
100%
Depressive Symptoms
100%
Chronic Depression
100%
Chronic Pain Treatment
100%
Serotonin
66%
Brainstem
66%
Selective Serotonin Reuptake Inhibitors
66%
Neurotransmitters
66%
Diabetic Neuropathy
66%
Chronic Pain Syndrome
66%
Physical Pain
66%
Venlafaxine
66%
Duloxetine
66%
Anxiety Disorders
33%
Central Nervous System
33%
Clinical Trials
33%
Worse Outcome
33%
Pathophysiology
33%
High Prevalence
33%
Effective Treatment
33%
Therapeutic Agents
33%
Pharmacological Therapy
33%
Medical Conditions
33%
Patient Health
33%
Patient Function
33%
Symptom Severity
33%
Spinal Cord
33%
Periodic Inspection
33%
Symptomatic Outcome
33%
Pain Transmission
33%
Change Assessment
33%
Somatic Symptoms
33%
Health-related Quality of Life
33%
Peripheral Nervous System
33%
Tricyclic Antidepressants
33%
Pain Symptoms
33%
Neural Pathways
33%
Moderate to Severe Pain
33%
Depression Disorder
33%
Serotonin-norepinephrine Reuptake Inhibitors
33%
Extended Use
33%
Overall Quality of Life
33%
Medicine and Dentistry
Chronic Pain
100%
Chronic Depression
100%
Antidepressant
100%
Depression
75%
Serotonin
50%
Noradrenalin
50%
Chronic Pain Syndrome
50%
Venlafaxine
50%
Diabetic Neuropathy
50%
Duloxetine
50%
Brainstem
50%
Neurotransmitter
50%
Clinical Trial
25%
Prevalence
25%
Therapeutic Agent
25%
Pathophysiology
25%
Quality of Life
25%
Somatics
25%
Anxiety Disorder
25%
Peripheral Nervous System
25%
Tricyclic Antidepressant
25%
Neural Pathway
25%
Serotonin-Norepinephrine Reuptake Inhibitor
25%
Selective Serotonin Reuptake Inhibitor
25%
Central Nervous System
25%
Neuroscience
Antidepressant
100%
Depression
100%
Serotonin
66%
Norepinephrine
66%
Brainstem
66%
Neurotransmitter
66%
Diabetic Neuropathy
66%
Duloxetine
66%
Chronic Pain Syndrome
66%
Venlafaxine
66%
Central Nervous System
33%
Selective Serotonin Reuptake Inhibitor
33%
Anxiety Disorder
33%
Tricyclic Antidepressant
33%
Somatics
33%
Serotonin-Norepinephrine Reuptake Inhibitor
33%
Neural Pathway
33%
Peripheral Nervous System
33%
Pharmacology, Toxicology and Pharmaceutical Science
Antidepressant
100%
Chronic Pain
100%
Chronic Depression
100%
Depression
50%
Noradrenalin
33%
Neurotransmitter
33%
Venlafaxine
33%
Diabetic Neuropathy
33%
Serotonin
33%
Duloxetine
33%
Pain
33%
Selective Serotonin Reuptake Inhibitor
16%
Clinical Trial
16%
Pathophysiology
16%
Prevalence
16%
Serotonin-Norepinephrine Reuptake Inhibitor
16%
Anxiety Disorder
16%
Tricyclic Antidepressant
16%